Abstract Mesenchymal stem cell-based therapies are a promising strategy for the regeneration of articular cartilage and management of knee osteoarthritis (KOA). Nevertheless, the comparative therapeutic efficacy of single versus repeated intra-articular injections of human adipose-derived mesenchymal stem cells (haMSCs) for cartilage preservation in animal models of osteoarthritis, particularly in the lateral and medial femoral condyles and intercondylar fossa, remain unclear.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Xingyi
Contact Xingyi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack